Cabaletta Bio, Inc. Quarterly report [Sections 13 or 15(d)]

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2026

Schedule of Basic and Diluted Earnings Per Share


	Three Months Ended March 31,
	2026			2025
	Voting common stock			Voting common stock
Basic and diluted net loss per share:
Net loss	$	(43,515	)	$	(35,943	)
Weighted average number of shares outstanding		112,025,474			50,743,101
Net loss per share, basic and diluted	$	(0.39	)	$	(0.71	)

Schedule of Antidilutive Shares Excluded from Calculation of Diluted Net Loss Per Share

The following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share, as their effect is anti-dilutive:


	Three Months Ended March 31,
	2026		2025
Stock options to purchase common stock		17,590,362		14,066,205
Warrants to purchase common stock		50,315,090		—
Total		67,905,452		14,066,205